75 related articles for article (PubMed ID: 24511005)
1. ESR1 promoter methylation in squamous cell cervical cancer.
Kirn V; Zaharieva I; Heublein S; Thangarajah F; Friese K; Mayr D; Jeschke U
Anticancer Res; 2014 Feb; 34(2):723-7. PubMed ID: 24511005
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Alteration by DNA Methylation of ESR1, MYOD1 and hTERT Gene Promoters is Useful for Prediction of Response in Patients of Locally Advanced Invasive Cervical Carcinoma Treated by Chemoradiation.
Sood S; Patel FD; Ghosh S; Arora A; Dhaliwal LK; Srinivasan R
Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):720-7. PubMed ID: 26344356
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor promoter methylation predicts survival in low-grade ovarian carcinoma patients.
Kirn V; Shi R; Heublein S; Knabl J; Guenthner-Biller M; Andergassen U; Fridrich C; Malter W; Harder J; Friese K; Mayr D; Jeschke U
J Cancer Res Clin Oncol; 2014 Oct; 140(10):1681-7. PubMed ID: 24908329
[TBL] [Abstract][Full Text] [Related]
4. [Association of ESR1 methylation at promoter region with progression of cervical lesion in Uyghur women].
Aliyeguli A; Abida A; He H; Abulizi A
Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):765-6. PubMed ID: 23302339
[No Abstract] [Full Text] [Related]
5. Loss of estrogen receptor 1 enhances cervical cancer invasion.
Zhai Y; Bommer GT; Feng Y; Wiese AB; Fearon ER; Cho KR
Am J Pathol; 2010 Aug; 177(2):884-95. PubMed ID: 20581058
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Changes of the ESR1 Gene in Breast Tissue of Healthy Women: A Missing Link with Breast Cancer Risk Factors?
Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Younosi N; Meysamie A; Mansoori Y; Bastami M; Tavakkoly-Bazzaz J
Genet Test Mol Biomarkers; 2017 Aug; 21(8):464-470. PubMed ID: 28708432
[TBL] [Abstract][Full Text] [Related]
7. ESR1-promoter-methylation status in primary breast cancer and its corresponding metastases.
Kirn V; Strake L; Thangarajah F; Richters L; Eischeid H; Koitzsch U; Odenthal M; Fries J
Clin Exp Metastasis; 2018 Oct; 35(7):707-712. PubMed ID: 30173322
[TBL] [Abstract][Full Text] [Related]
8. CDH1 promoter methylation in patients with cervical carcinoma: a systematic meta-analysis with trial sequential analysis.
Liu G
Future Oncol; 2018 Jan; 14(1):51-63. PubMed ID: 29237293
[TBL] [Abstract][Full Text] [Related]
9. Aberrant gene-specific DNA methylation signature analysis in cervical cancer.
Bhat S; Kabekkodu SP; Varghese VK; Chakrabarty S; Mallya SP; Rotti H; Pandey D; Kushtagi P; Satyamoorthy K
Tumour Biol; 2017 Mar; 39(3):1010428317694573. PubMed ID: 28351298
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between DNA Methylation of ZNF772 Promoter Region and Cervical Cancer].
Li M; Li O; Sun J; Zheng X; Ma D
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Apr; 42(2):164-171. PubMed ID: 32385021
[No Abstract] [Full Text] [Related]
11. Distinct DNA methylation profiles between adenocarcinoma and squamous cell carcinoma of human uterine cervix.
Lee EJ; Mcclelland M; Wang Y; Long F; Choi SH; Lee JH
Oncol Res; 2010; 18(9):401-8. PubMed ID: 20524398
[TBL] [Abstract][Full Text] [Related]
12. Status of p16(INK4a) and E-cadherin gene promoter methylation in Moroccan patients with cervical carcinoma.
Attaleb M; El hamadani W; Khyatti M; Benbacer L; Benchekroun N; Benider A; Amrani M; El Mzibri M
Oncol Res; 2009; 18(4):185-92. PubMed ID: 20112504
[TBL] [Abstract][Full Text] [Related]
13. Chemoradiation therapy induces
Sood S; Patel FD; Srinivasan R; Dhaliwal LK
Indian J Med Res; 2018 Feb; 147(2):151-157. PubMed ID: 29806603
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation of the VIM promoter in uterine cervical squamous cell carcinoma.
Lee MK; Jeong EM; Kim JH; Rho SB; Lee EJ
Oncology; 2014; 86(5-6):359-68. PubMed ID: 24942637
[TBL] [Abstract][Full Text] [Related]
15. Methylation of the RASSF1A gene promoter in Uigur women with cervical squamous cell carcinoma.
Pan Z; Li J; Pan X; Chen S; Wang Z; Li F; Qu S; Shao R
Tumori; 2009; 95(1):76-80. PubMed ID: 19366060
[TBL] [Abstract][Full Text] [Related]
16. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
[TBL] [Abstract][Full Text] [Related]
17. Quantitative p16 and ESR1 methylation in the peripheral blood of patients with non-small cell lung cancer.
Suga Y; Miyajima K; Oikawa T; Maeda J; Usuda J; Kajiwara N; Ohira T; Uchida O; Tsuboi M; Hirano T; Kato H; Ikeda N
Oncol Rep; 2008 Nov; 20(5):1137-42. PubMed ID: 18949413
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic regulation of human riboflavin transporter 2(hRFT2) in cervical cancers from Uighur women.
Ma JQ; Kurban S; Zhao JD; Li QZ; Hasimu A
Asian Pac J Cancer Prev; 2014; 15(6):2485-9. PubMed ID: 24761851
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of methylated GSTP1, p16, ESR1 and PITX2 in patients with breast cancer: A systematic meta-analysis under the guideline of PRISMA.
Sheng X; Guo Y; Lu Y
Medicine (Baltimore); 2017 Jul; 96(28):e7476. PubMed ID: 28700487
[TBL] [Abstract][Full Text] [Related]
20. DNA Methylation Status of the Estrogen Receptor α Gene in Canine Mammary Tumors.
Brandão YO; Toledo MB; Chequin A; Cristo TG; Sousa RS; Ramos EAS; Klassen G
Vet Pathol; 2018 Jul; 55(4):510-516. PubMed ID: 29566609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]